BioSpace News Archive

Business

BryoLogyx Increases Antigen Visibility for an Enhanced I-O Impact

Bryostatin-1 increases antigen expression on the surface of cancer cells, enabling them to be seen and killed by IO agents.

April 27, 2022
·
4 min read
·
Gail Dutton
Drug Development

BioMarin’s Record Q1 Driven by Recently Approved Achondroplasia Therapy

The Q1 results for Voxzogo gave BioMarin the confidence to raise its 2022 full-year guidance to between $100 million to $125 million (net product revenue) for the drug.

April 27, 2022
·
4 min read
·
Heather McKenzie
Business

Molecular Partners Collab Falls Victim to Amgen Strategic Pipeline Review

All development and commercialization rights for MP0310, a clinical stage immunomodulator intended to treat solid tumors, will be reverted to Molecular Partners.

April 27, 2022
·
2 min read
·
Jazmine Colatriano
Drug Development

Cassava Sciences Hits Back at NYT For Alleged “Pre-Set Narrative”

Cassava Sciences CEO Remi Barbier is hitting back at The New York Times, calling out the newspaper for an article that he claims misrepresented the research of his company.

April 27, 2022
·
3 min read
·
Alex Keown
Business

‘Tis the Season: Job Cuts and C-Suite Shifts at Novartis, BridgeBio and Nektar

Novartis, Nektar and BridgeBio confirm their plans to restructure their operation, including a number of their employees being laid off.

April 27, 2022
·
3 min read
·
Mark Terry
Policy

Congress Asks FDA to Reconsider Vaccine Delays for Kids Under 5

The U.S. Congress is calling for the coronavirus management plan to deliberate on the timeline for the approval and release of vaccines for children under 5 years old.

April 27, 2022
·
2 min read
·
Vanessa Doctor, RN
FDA

AviadoBio’s FTD Therapeutic Scores FDA, EC Orphan Drug Designation

AviadoBio is celebrating orphan drug designations from both the U.S. FDA and the European Commission for AVB-101, a gene therapy intended to treat frontotemporal dementia (FTD).

April 27, 2022
·
2 min read
·
Jazmine Colatriano, M.S.
Business

It’s Pfizer to the Rescue After Zentalis’ Shares Stumble at AACR

Zentalis Pharmaceuticals announced that Pfizer made a $25 million equity investment in the company.

April 27, 2022
·
3 min read
·
Hayley Shasteen
Hepatitis Diagnostic Test Market Analysis 2022-2028- Growing Burden Of Hepatitis Diseases And Rising Number Of Blood Donation And Blood Transfusion

Rising awareness about hepatitis symptoms and growing need for early diagnosis through public education and increasing occurrence of hepatitis across the globe are fueling global market growth.

April 27, 2022
·
7 min read
Business

Amgen Battles IRS Over Billions in “Wholly Unwarranted” Tax Penalties

Amgen held its earnings conference call on Wednesday for Q1 of 2022. Most notably, the company provided updates on its ongoing litigation with the Internal Revenue Service.

April 27, 2022
·
2 min read
·
Rosemary Scott